← back to search

Alison P. Galvani

Global Vaccines (United States) · US
Area of research
Modeling and Simulation · Infectious Diseases
Research interest
Research interests include COVID-19 epidemiological studies, Vaccine Coverage and Hesitancy, SARS-CoV-2 and COVID-19 Research, and Influenza Virus Research Studies.
h-index
75
citations
23,289
works
416
NIH funding
primary concept
Medicine
email

Recent publications

The health and economic repercussions of declining MMR coverage in the United States.
2026cited by 0position: contributordoi
School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks.
2026cited by 0position: contributordoi
Containment scenarios for post-spillover transmission chains of avian influenza H5N1 from poultry to humans
Nature Health 2026cited by 0position: middledoi
The health and economic repercussions of declining MMR coverage in the United States
Proceedings of the National Academy of Sciences 2026cited by 0position: lastdoi
Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges
Nature Communications 2025cited by 76position: lastdoi
Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges.
2025cited by 27position: contributordoi
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Nature Medicine 2025cited by 26position: lastdoi
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults.
2025cited by 17position: contributordoi
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
BMC Infectious Diseases 2025cited by 5position: middledoi
Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study
The Lancet Regional Health - Americas 2025cited by 5position: middledoi
Quantifying the mortality and morbidity impact of medicaid work requirements: a modeling study
The Lancet Regional Health - Americas 2025cited by 3position: contributordoi
School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks
Annals of Internal Medicine 2025cited by 2position: lastdoi
Racial and Ethnic Disparities in Meningococcal Vaccination Coverage and Disease Burden Among U.S. Adolescents
Journal of Adolescent Health 2025cited by 1position: middledoi
The synergy of therapeutic vaccination and timely diagnosis for TB control in high-burden settings: Nunavut as a case study
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2025cited by 0position: lastdoi
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study
Vaccine 2024cited by 15position: middledoi
Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults
JAMA Network Open 2024cited by 8position: middledoi
Incorporating Social Determinants of Health in Infectious Disease Models: A Systematic Review of Guidelines
Medical Decision Making 2024cited by 7position: middledoi
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States
Annals of Internal Medicine 2024cited by 4position: lastdoi
Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
2024cited by 3position: contributordoi
A Generalizable Theory-Driven Agent-Based Framework to Study Conflict-Induced Forced Migration
Proceedings of the AAAI Conference on Artificial Intelligence 2024cited by 1position: middledoi
Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review
Public health reviews 2024cited by 0position: middledoi
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study
The Lancet Regional Health - Americas 2023cited by 69position: middledoi
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States
Clinical Infectious Diseases 2023cited by 35position: lastdoi
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States
medRxiv 2023cited by 13position: lastdoi
Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City
The Lancet Regional Health - Americas 2023cited by 10position: lastdoi
Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City
The Lancet Regional Health - Americas 2023cited by 5position: contributordoi
Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination
JAMA Network Open 2023cited by 3position: lastdoi
Cost-Effectiveness Analysis of Nirsevimab and RSVpreF Vaccine Prevention Strategies for Respiratory Syncytial Virus Disease in infants: A Canadian Immunisation Research Network (CIRN) Study
medRxiv 2023cited by 3position: middledoi
Purifying selection and adaptive evolution proximate to the zoonosis of SARS-CoV-1 and SARS-CoV-2
2023cited by 0position: contributordoi
Modeling a High-Uptake Booster Scenario on the COVID-19 Burden and Healthcare Costs in New York City
SSRN Electronic Journal 2023cited by 0position: lastdoi

Grants

Expeditions: Collaborative Research: Global Pervasive Computational Epidemiology
NSF1918784$901,5262020–2025PIRePORTER
RAPID: Curbing the COVID-19 outbreak in the United States
NSF2027755$199,9932020–2021PIRePORTER
Collaborative Research: Signaling Prosociality: Harnessing Impure Motives to Help Others
NSF1529983$57,6262015–2018PIRePORTER
RAPID: Optimal allocation of both non-pharmaceutical and pharmaceutical interventions toward controlling Ebola virus transmission in West Africa
NSF1514673$199,8902014–2016PIRePORTER
COLLABORATIVE RESEARCH: Cross-national differences in vaccination as unselfish behavior
NSF1227390$371,2312012–2016PIRePORTER
Collaborative Research: Dynamic Risk Perceptions about Mexican Swine Flu
NSF0940018$57,1252009–2010PIRePORTER
Collaborative Research: Modeling and Behavioral Evaluation of Social Dynamics in Prevention Decisions
NSF0624117$377,4842007–2011PIRePORTER

Frequent collaborators

Seyed M. Moghadas · York University69 papers (2020–2026)Meagan C. Fitzpatrick · Yale University41 papers (2016–2026)Burton H. Singer · University of Florida28 papers (2020–2026)Abhishek Pandey · Indian Institute of Technology Mandi26 papers (2014–2026)Affan Shoukat · University of Regina25 papers (2020–2026)Chad R. Wells · Yale University24 papers (2015–2026)Thomas N. Vilches · York University21 papers (2020–2023)Pratha Sah · P.V. Narsimha Rao Telangana Veterinary University20 papers (2020–2022) · 19 papers (2019–2026)Jeffrey P. Townsend · Yale University16 papers (2013–2022)Joanne M. Langley · Alberta Children's Hospital13 papers (2020–2025)Martial L. Ndeffo-Mbah · Texas A&M University12 papers (2013–2019)Lauren Ancel Meyers · The University of Texas at Austin10 papers (2013–2020) · 10 papers (2021–2026)Katherine E. Atkins · University of London10 papers (2012–2019)Kevin Zhang · McMaster University9 papers (2020–2021) · 7 papers (2020–2026) · 6 papers (2019–2026)Jeffrey P. Townsend · University of Wisconsin–Madison6 papers (2019–2023) · 6 papers (2020–2026)